Company / Debt per Share
PTC Therapeutics, Inc. Debt per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$3.77
FY2024
5-year range
$3.77 / $8.07
FY2020-FY2024
Trend
-3.0%
vs FY2023
Sector context
#33 of 82
Health Care
What the data says
At $3.77, PTC Therapeutics, Inc.'s debt per share ranks #50 of 82 in the Health Care sector. Debt per Share has fluctuated over the past 9 years, ranging from $2.90 in FY2016 to $8.07 in FY2022.
Based on SEC 10-K filings.
3.77 in FY2024 with a 5-year CAGR of -5.5%.
Improved from $8.07 to $3.77 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -2.3%
- 5-Year CAGR
- -5.5%
- 10-Year CAGR
- -
Sector benchmark
#50 of 82 in Health CareTop 60% of 82This company $3.77 Sector average $126.59
▼
-97.0% below sector average
Key checks
Key Insights
- In FY2024, debt per share decreased 3.0% year-over-year.
- Ranks #33 out of 82 companies in the Health Care sector.
- Peak debt per share was recorded in FY2022.
- Lowest debt per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $3.77 | -3.0% |
| FY2023 | $3.89 | -51.8% |
| FY2022 | $8.07 | +99.6% |
| FY2021 | $4.04 | -19.0% |
| FY2020 | $4.99 | -0.0% |
| FY2019 | $4.99 | +47.0% |
| FY2018 | $3.40 | -19.9% |
| FY2017 | $4.24 | +46.5% |
| FY2016 | $2.90 | +3.7% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026